Vicc

Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy. Read More

Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.” Read More

A new study offers clues on why melanoma patients who are treated with oral drugs inhibiting the BRAF gene are at increased risk for developing secondary skin cancers. Read More

Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk. Read More

A molecule detectable in urine may be helpful in diagnosing colon cancer. Read More

Investigators from Vanderbilt-Ingram Cancer Center and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival. Read More

Women who eat at least three servings of fish per week have a reduced risk of developing some types of colon polyps according to a new study by Vanderbilt-Ingram Cancer Center investigators. Read More

Severity of cancer could be predicted by prostate size. Read More

A large, retrospective study of the children of childhood cancer survivors who were treated with radiation therapy and/or some forms of chemotherapy found that the offspring do not have an increased risk for birth defects compared with children of cancer survivors who did not receive these treatments. Read More

The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health. Read More